NDA 216493 describes FONDAPARINUX SODIUM, which is a drug marketed by
Dr Reddys Labs Ltd,
Eugia Pharma,
Hangzhou Zhongmei,
Hengrui Pharma, and
Scinopharm Taiwan, and is included in five NDAs. It is available from
six suppliers. Additional details are available on the
FONDAPARINUX SODIUM profile page.
The generic ingredient in FONDAPARINUX SODIUM is
fondaparinux sodium. There are fourteen
drug master file entries for this compound. Seven
suppliers are listed for this compound. Additional details are available on the
fondaparinux sodium profile page.